Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase

Infection and Immunity

Volumn 75, Issue 8, 2007, Pages 4088-4096

  Taubman, Martin A ^a   Han, Xiaozhe ^a   LaRosa, Karen B ^a   Socransky, Sigmund S ^a   Smith, Daniel J ^a  

^a FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIAL ANTIGEN; BACTERIAL DNA; CYTOKINE; GLUCOSYLTRANSFERASE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 5; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTAL CARIES; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; RAT; SPLEEN CELL; STREPTOCOCCUS SOBRINUS;

ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOKINES; DENTAL CARIES; DNA, BACTERIAL; FEMALE; GLUCOSYLTRANSFERASES; IMMUNOGLOBULIN G; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; STREPTOCOCCUS SOBRINUS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES;

EID: 34547640077     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00623-07     Document Type: Article

References (55)

1. Alexander, W. S., and D. J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22:503-529.
2. Babu, S., V. Kumaraswami, and T. B. Nutman. 2005. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes. Infect. Immun. 73: 3394-3401.
3. Berlato, C., M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni. 2002. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168:6404-6411.
4. Cooney, R. N. 2002. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 17:83-90.
5. Cooper, C. L., H. L. Davis, M. L. Morris, S. M. Efler, M. A. Adhami, A. M. Krieg, D. W. Cameron, and J. Heathcote. 2004. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J. Clin. Immunol. 24:693-701.
6. Decker, T., F. Schneller, T. Sparwasser, T. Tretter, G. B. Lipford, H. Wagner, and C. Peschel. 2000. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95:999-1006.
7. DeSeau, V., N. Rosen, and J. B. Bolen. 1987. Analysis of pp60c-src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells. J. Cell. Biochem. 35:113-128.
8. Diehl, S., J. Anguita, A. Hoffmeyer, T. Zapton, J. N. Ihle, E. Fikrig, and M. Rincon. 2000. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13:805-815.
9. Ding, Y., D. Chen, A. Tarcsafalvi, R. Su, L. Qin, and J. S. Bromberg. 2003. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170:1383-1391.
10. Eastcott, J. W., C. J. Holmberg, F. E. Dewhirst, T. R. Esch, D. J. Smith, and M. A. Taubman. 2001. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid. Vaccine 19:1636-1642.
11. Elkins, K. L., T. R. Rhinehart-Jones, S. Stibitz, J. S. Conover, and D. M. Klinman. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-2298.
12. Falkler, W. A., Jr., E. B. Clayman, and D. F. Shaefer. 1983. Haemolysis of human erythrocytes by the Fusobacterium nucleatum associated with periodontal disease. Arch. Oral Biol. 28:735-739.
13. Fan, M. W., Z. Bian, Z. X. Peng, Y. Zhong, Z. Chen, B. Peng, and R. Jia. 2002. A DNA vaccine encoding a cell-surface protein antigen of Streptococcus mutans protects gnotobiotic rats from caries. J. Dent. Res. 81:784-787.
14. Gigova, L., P. Wishart, A. Uscheva, M. Ivanova, S. Bardarov, E. Jay, and I. Ivanov. 1989. Expression of repetitive human calcitonin genes in Escherichia coli. Biotechnol. Appl. Biochem. 11:401-412.
15. Han, T. K., and M. L. Dao. 2005. Differential immunogenicity of a DNA vaccine containing the Streptococcus mutans wall-associated protein A gene versus that containing a truncated derivative antigen A lacking in the hydrophobic carboxyterminal region. DNA Cell Biol. 24:574-581.
16. Heeg, K., and A. Dalpke. 2003. TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity. Vaccine 21(Suppl. 2):S61-S67.
17. Heeg, K., T. Sparwasser, G. B. Lipford, H. Hacker, S. Zimmermann, and H. Wagner. 1998. Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells. Eur. J. Clin. Microbiol. Infect. Dis. 17:464-469.
18. Ho, P. P., P. Fontoura, M. Platten, R. A. Sobel, J. J. DeVoss, L. Y. Lee, B. A. Kidd, B. H. Tomooka, J. Capers, A. Agrawal, R. Gupta, J. Zemik, M. K. Yee, B. J. Lee, H. Garren, W. H. Robinson, and L. Steinman. 2005. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease. J. Immunol. 175:6226-6234.
19. Hobson, P., C. Barnfield, A. Barnes, and L. S. Klavinskis. 2003. Mucosal immunization with DNA vaccines. Methods 31:217-224.
20. Ilangumaran, S., and R. Rottapel. 2003. Regulation of cytokine receptor signaling by SOCS1. Immunol. Rev. 192:196-211.
21. Ishii, K. J., K. Suzuki, C. Coban, F. Takeshita, Y. Itoh, H. Matoba, L. D. Kohn, and D. M. Klinman. 2001. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167:2602-2607.
22. Jahrsdorfer, B., L. Muhlenhoff, S. E. Blackwell, M. Wagner, H. Poeck, E. Hartmann, R. Jox, T. Giese, B. Emmerich, S. Endres, G. J. Weiner, and G. Hartmann. 2005. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin. Cancer Res. 11:1490-1499.
23. Jia, R., J. H. Guo, M. W. Fan, Z. Bian, Z. Chen, B. Peng, and B. Fan. 2004. Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats. Vaccine 22:2511-2516.
24. Katz, J., Q. B. Yang, P. Zhang, J. Potempa, J. Travis, S. M. Michalek, and D. F. Balkovetz. 2002. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains. Infect. Immun. 70:2512-2518.
25. Kawazoe, Y., T. Naka, M. Fujimoto, H. Kohzaki, Y. Morita, M. Narazaki, K. Okumura, H. Saitoh, R. Nakagawa, Y. Uchiyama, S. Akira, and T. Kishimoto. 2001. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193:263-269.
26. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-591.
27. Kinjyo, I., H. Inoue, S. Hamano, S. Fukuyama, T. Yoshimura, K. Koga, H. Takaki, K. Himeno, G. Takaesu, T. Kobayashi, and A. Yoshimura. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203:1021-1031.
28. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760.
29. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
30. Krisanaprakornkit, S., A. Weinberg, C. N. Perez, and B. A. Dale. 1998. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun. 66:4222-4228.
31. Kuboniwa, M., A. Amano, S. Shizukuishi, I. Nakagawa, and S. Hamada. 2001. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect. Immun. 69:2972-2979.
32. Larsen, L., and C. Ropke. 2002. Suppressors of cytokine signalling: SOCS. APMIS 110:833-844.
33. Lipford, G. B., T. Sparwasser, M. Bauer, S. Zimmermann, E. S. Koch, K. Heeg, and H. Wagner. 1997. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27:3420-3426.
34. Lobell, A., R. Weissert, S. Eltayeb, K. L. de Graaf, J. Wefer, M. K. Storch, H. Lassmann, H. Wigzell, and T. Olsson. 2003. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response. J. Immunol. 170:1806-1813.
35. McCluskie, M. J., and H. L. Davis. 1999. Novel strategies using DNA for the induction of mucosal immunity. Crit. Rev. Immunol. 19:303-329.
36. Michalek, S. M., J. Katz, N. K. Childers, M. Martin, and D. F. Balkovetz. 2002. Microbial/host interactions: mechanisms involved in host responses to microbial antigens. Immunol. Res. 26:223-234.
37. Neujahr, D. C., C. F. Reich, and D. S. Pisetsky. 1999. Immunostimulatory properties of genomic DNA from different bacterial species. Immunobiology 200:106-119.
38. Nicola, N. A., and C. J. Greenhalgh. 2000. The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. Exp. Hematol. 28:1105-1112.
39. Okuda, K., and I. Takazoe. 1988. The role of Bacteroides gingivalis in periodontal disease. Adv. Dent. Res. 2:260-268.
40. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165-169.
41. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
42. Sasaki, H., Y. Okamatsu, T. Kawai, R. Kent, M. A. Taubman, and P. Stashenko. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J. Periodontal Res. 39:432-441.
43. Seki, Y., K. Hayashi, A. Matsumoto, N. Seki, J. Tsukada, J. Ransom, T. Naka, T. Kishimoto, A. Yoshimura, and M. Kubo. 2002. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. USA 99:13003-13008.
44. Smith, D. J., and M. A. Taubman. 1987. Oral immunization of humans with Streptococcus sobrinus glucosyltransferase. Infect. Immun. 55:2562-2569.
45. Sparwasser, T., T. Miethke, G. Lipford, A. Erdmann, H. Hacker, K. Heeg, and H. Wagner. 1997. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27:1671-1679.
46. Stacey, K. J., M. J. Sweet, and D. A. Hume. 1996. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:2116-2122.
47. Stark, J. L., and A. H. Cross. 2006. Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis. Int. Immunol. 18:347-353.
48. Taubman, M. A., C. J. Holmberg, and D. J. Smith. 2001. Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries. Infect. Immun. 69:4210-4216.
49. Taubman, M. A., and D. A. Nash. 2006. The scientific and public-health imperative for a vaccine against dental caries. Nat. Rev. Immunol. 6:555-563.
50. Torres, R. D., C. A. Oletta, and H. Zlotnik. 1996. A rapid and gentle method for isolation of genomic DNA from pathogenic Nocardia spp. Clin. Diagn. Lab. Immunol. 3:601-604.
51. Wagner, H. 2002. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol. 5:62-69.
52. Whiteside, T. L., A. Gambotto, A. Albers, J. Stanson, and E. P. Cohen. 2002. Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo. Proc. Natl. Acad. Sci. USA 99:9415-9420.
53. Wingender, G., N. Garbi, B. Schumak, F. Jungerkes, E. Endl, D. von Bubnoff, J. Steitz, J. Striegler, G. Moldenhauer, T. Tuting, A. Heit, K. M. Huster, O. Takikawa, S. Akira, D. H. Busch, H. Wagner, G. J. Hammerling, P. A. Knolle, and A. Limmer. 2006. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36:12-20.
54. Yanagita, M., T. Hiroi, N. Kitagaki, S. Hamada, H. O. Ito, H. Shimauchi, S. Murakami, H. Okada, and H. Kiyono. 1999. Nasopharyngeal- associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J. Immunol. 162:3559-3565.
55. Yonezawa, H., K. Ishihara, and K. Okuda. 2001. Arg-gingipain A DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect. Immun. 69:2858-2864.